机构:[1]Technology Transfer Center, Kunming Medical University, 1168 West Chunrong Road, Yuhua Avenue, Chenggong District, Kunming 650500, Yunnan, China[2]Biomedical Engineering Research Center, Kunming Medical University, 1168 West Chunrong Road, Yuhua Avenue, Chenggong District, Kunming 650500, Yunnan, China[3]Department of Medical Laboratory Sciences, the First Affiliated Hospital of Kunming Medical University, Kunming, China昆明医科大学附属第一医院[4]Department of Rehabilitation, Affiliated Hospital of Jining Medical University, Jining, China
Keloids are a common dermal pathological disorder characterized by the excessive deposition of extracellular matrix components; however, the exact pathogenesis of the disease is still not clear. Studies increasingly suggest that microRNAs (miRNAs) can play a key role in the process of keloid scarring. In this study, the valuable miRNAs and target genes were screened and the interaction network was constructed. We also predicted target genes of reported miRNAs using TargetScan and miRTarBase software. Cytoscape 3.0.1 further showed the interaction network of miRNA and target genes. Among the various miRNAs involved in keloid pathogenesis, miRNA-21, miRNA-141-3p, miRNA-181a, and miRNA-205 were thought to up-regulate the proliferation and decrease apoptosis of keloid-derived fibroblasts through the PI3K/Akt/mammalian target of rapamycin (mTOR) signaling pathway. miRNA-637 and miRNA-1224 inhibited keloid fibroblasts proliferation and promoted apoptosis via the transforming growth factor (TGF)-beta 1/Smad3 signaling pathway. miRNA-21 was also involved in mitochondrial-mediated apoptosis and miRNA-31 targeted vascular endothelial growth factor (VEGF) signaling pathway. miRNA-199a may be one key factor in the cell cycle checkpoint signal pathway of keloid-derived fibroblasts. It was also found that miRNA-29a and miRNA-196a mediated collagen metabolism. These pivotal miRNAs and regulatory processes further improve the data on the epigenetic mechanisms of keloids and provide hope for the use of small molecules in the treatment of keloids.
基金:
The authors are supported by grants from the National Natural
Science Foundation of China (NSFC; Grant no. 81560502), the
National Natural Science Foundation of Yunnan Province (Grant no.
2017FB116), the Talent Project of Yunnan Province (Lechun Lyu) and
100 Talents Program of Kunming Medical University (Lechun Lyu).
第一作者机构:[1]Technology Transfer Center, Kunming Medical University, 1168 West Chunrong Road, Yuhua Avenue, Chenggong District, Kunming 650500, Yunnan, China
通讯作者:
通讯机构:[1]Technology Transfer Center, Kunming Medical University, 1168 West Chunrong Road, Yuhua Avenue, Chenggong District, Kunming 650500, Yunnan, China[2]Biomedical Engineering Research Center, Kunming Medical University, 1168 West Chunrong Road, Yuhua Avenue, Chenggong District, Kunming 650500, Yunnan, China
推荐引用方式(GB/T 7714):
Lechun Lyu,Yu Zhao,Hongquan Lu,et al.Integrated Interaction Network of MicroRNA Target Genes in Keloid Scarring[J].MOLECULAR DIAGNOSIS & THERAPY.2019,23(1):53-63.doi:10.1007/s40291-018-0378-0.
APA:
Lechun Lyu,Yu Zhao,Hongquan Lu,Zijie Liu,Jiazhi Guo...&Xiang Li.(2019).Integrated Interaction Network of MicroRNA Target Genes in Keloid Scarring.MOLECULAR DIAGNOSIS & THERAPY,23,(1)
MLA:
Lechun Lyu,et al."Integrated Interaction Network of MicroRNA Target Genes in Keloid Scarring".MOLECULAR DIAGNOSIS & THERAPY 23..1(2019):53-63